Earendil Labs
About Earendil Labs
Earendil Labs develops AI-powered platforms to transform protein therapeutics research and development. The company applies deep learning and high-throughput biology to discover and develop novel protein-based drugs. Their technology is focused on accelerating protein therapeutics discovery and optimization, enabling faster progression from concept to therapeutic candidates. Earendil Labs operates in the biotechnology space, pursuing advanced methods for drug development and protein design.
Recent News
Isomorphic Labs Raises $2.1 B to Expand AI-Driven Drug Discovery Platform
AI Giant Anthropic Leans Into Life Sciences With $400M Coefficient Bio Catch
What the Smart Money Just Bought in Healthcare and Life Sciences VC Over the Last Sixty Days
Earendil Labs Begins Phase 2a Trial of Ulcerative Colitis Therapy